Page 28 - Journal of Structural Heart Disease Volume 5, Issue 5

New Technology
Journal of Structural Heart Disease, October 2019, Volume 5, Issue 5:221-228
DOI: https://doi.org/10.12945/j.jshd.2019.002.19
Received: January 26, 2019 Accepted: February 12, 2019 Published online: October 2019
Transcatheter Trans-aortic Retrograde Approach for the Closure of Perimembranous Ventricular Septal Defects using Cocoon [Amplatzer Duct Occluder I Like] Device – An Initial Experience from a Single Centre
Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC*, Kumar Narayanan, MD, DM, Edla Arjun Padma Kumar, MD, DM
Department of Cardiology, Maxcure-Mediciti Hospitals, Hyderabad, Telangana, India
Abstract
Aims & Objective: Transcatheter ventricular septal de- fect (VSD) device closure is usually performed using the antegrade approach [1–3]. A few case series of a retrograde technique using the Amplatzer duct occlud- er (ADO) II device have been reported [4, 5]. We aimed to assess the feasibility and safety of a retrograde clo- sure technique using an ADO I like device, which is used for the closure of patent ductus arteriosus (PDA).
Methods: Between June 2015 and January 2018, eight consecutive, consenting cases with congenital perimem- branous VSDs underwent trans-aortic device closure us- ing an ADO I like device in a single tertiary care center.
Results: The median age was 17.1 years (5-32, SD 17.125 years) with 3 males and 5 females. Mean defect size was 6.6 mm (4.5 - 8.6 mm, SD 6.6125), with a median aortic rim of 3.4 mm (2-5, SD 3.4125). Median Qp/Qs and right ventricular systolic pressure was 1.8 (1.6-2.1, SD 1.825) and 41.3 mm Hg (33-50, SD 41.25) respectively. Median fluoroscopy and procedure times were 13.3 (10.6-15.7, SD 13.275) and 23.5 (18.2-27.2, SD 22.722) minutes re- spectively. The defects were successfully closed with no residual shunt in all 8 patients (100%). There was no
semilunar or atrioventricular valve leaflet entrapment or regurgitation. There were no instances of acute de- vice dislodgement or Atrioventricular (AV) block. Over a median follow up of 18 months, all eight patients re- mained symptom free with no residual shunt or late complications.
Conclusion: In this initial experience, trans-aortic, ret- rograde VSD device closure using an ADO I like device appears feasible and safe in patients with perimembra- nous VSDs which a cost effective alternative to routine use of the ADO II device.
Copyright © 2019 Science International Corp.
Key Words
Ventricular septal defects • Device closure • Duct occluder
Introduction
Transcatheter ventricular septal defect (VSD) de- vice closure is a commonly performed procedure to close perimembranous VSDs (PMVSD), especially those that are moderately restrictive without severe pulmonary artery hypertension. Transcatheter clo-
* Corresponding Author:
Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC
Department of Cardiology
Maxcure-Mediciti Hospitals
Opposite Secretariat, Hyderabad, Telangana, India, 500063
Tel. +91 93 9317 8738; Fax: +91 40 2331 2783; E-Mail: pankaj_jariwala@hotmail.com
Fax +1 203 785 3346
E-Mail: jshd@scienceinternational.org http://structuralheartdisease.org/
© 2019 Journal of Structural Heart Disease Published by Science International Corp. ISSN 2326-4004
Accessible online at:
http://structuralheartdisease.org/